Benitec Biopharma Inc. 10-Q filing
Filed 2026-02-12 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0001193125-26-047737
- Form type
- 10-Q
- CIK
- 0001808898
- Primary document
- https://www.sec.gov/Archives/edgar/data/1808898/000119312526047737/bntc-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Benitec Biopharma Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-23.2M | - | - |
| Net Income | $-20.8M | - | - |
| Eps Basic | -0.48 | - | - |
| Eps Diluted | -0.48 | - | - |
| Cash And Equivalents | $188.8M | - | - |
| Total Assets | $190.7M | - | - |
| Total Liabilities | $3.3M | - | - |
| Shareholders Equity | $187.4M | - | - |
| Operating Cash Flow | $-7.1M | - | - |
| Capital Expenditures | $11,000 | - | - |